Gliomatosis cerebri was removed from the 2016 WHO classification but the clinical problem of gliomatosis remains. For many of these patients, re-irradiation of the whole brain may be the only option. We have employed pulsed reduced dose rate (PRDR) radiation therapy to limit the toxicity of whole brain re-irradiation in this patient population.
展开▼